Thursday, October 29, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

ozempic

5 stories tagged "ozempic"

Drugs & FDA

Federal Agents Seized Counterfeit Ozempic and Warned the Public. Prosecutors Say the Smuggling Kept Going for Months.

The counterfeits came from China with fake needles and packaging and sold to distributors at a discount. The indictment says the alleged scheme kept running for months after the FDA had already seized counterfeit Ozempic and warned the country.

Metabolic & Weight

The Hunger Neurons Ozempic Was Meant to Silence Are the Ones Burning Your Fat

Silence the hunger neurons and semaglutide keeps killing appetite, but in Yale's female mice the lost fat came back within 15 days.

Brain & Aging

The Craving Brake Nobody Mapped: How GLP-1 Drugs Quiet Cravings From the Lateral Septum

The anti-craving effect pushing people to use a diabetes shot off-label against drinking traces to a brain region built to inhibit, not to reward, and the human evidence is still just two small trials deep.

Metabolic & Weight

The Ozempic 'Resistance' Headline the Data Didn't Quite Earn

A new study identifies PAM-gene variants tied to weaker six-month HbA1c response to GLP-1 diabetes drugs, but the 'why Ozempic may not work' framing imports a weight-loss conclusion the paper doesn't reach, and the buried trials that used longer-acting GLP-1 drugs showed no carrier effect at all.

Cancer

Ozempic's 30 Percent Breast-Cancer Headline, and the Trial Evidence It Walked Past

A single-system observational study at ASCO 2026 attached a roughly 30% lower breast-cancer rate to GLP-1 use. The randomized record already on the table is quieter.